Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Maseki

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|December 15, 1985
Possible association of a new translocation, t(7;11)(p15;p15), with Ph1 chromosome-negative chronic myelogenous leukemiaY Kaneko, N Maseki, N Takasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1985
[Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia]K Sampi, Y Kaneko, N Maseki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1H Miyoshi, K Shimizu, T Kozu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1987
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients]K Sampi, R Kumai, N Maseki, et al.
Cancer|September 15, 1986
Myeloblastoma with an 8;21 chromosome translocation in acute myeloblastic leukemiaR Abe, H Umezu, T Uchida, et al.
Blood|March 15, 1993
The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1N Maseki, H Miyoshi, K Shimizu, et al.
Blood|August 1, 1988
Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive "angioimmunoblastic lymphadenopathy with dysproteinemia-type" featuresY Kaneko, N Maseki, M Sakurai, et al.
Blood|July 13, 2000
AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilonK Shimizu, I Kitabayashi, N Kamada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification studyY Kaneko, N Kanda, N Maseki, et al.
Cancer Research|December 15, 1987
Chromosome abnormalities in malignant lymphoma in patients from SaitamaN Maseki, Y Kaneko, M Sakurai, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|December 15, 1985
Possible association of a new translocation, t(7;11)(p15;p15), with Ph1 chromosome-negative chronic myelogenous leukemiaY Kaneko, N Maseki, N Takasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1985
[Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia]K Sampi, Y Kaneko, N Maseki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1H Miyoshi, K Shimizu, T Kozu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1987
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients]K Sampi, R Kumai, N Maseki, et al.
Cancer|September 15, 1986
Myeloblastoma with an 8;21 chromosome translocation in acute myeloblastic leukemiaR Abe, H Umezu, T Uchida, et al.
Blood|March 15, 1993
The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1N Maseki, H Miyoshi, K Shimizu, et al.
Blood|August 1, 1988
Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive "angioimmunoblastic lymphadenopathy with dysproteinemia-type" featuresY Kaneko, N Maseki, M Sakurai, et al.
Blood|July 13, 2000
AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilonK Shimizu, I Kitabayashi, N Kamada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification studyY Kaneko, N Kanda, N Maseki, et al.
Cancer Research|December 15, 1987
Chromosome abnormalities in malignant lymphoma in patients from SaitamaN Maseki, Y Kaneko, M Sakurai, et al.
Pageof 7